Showing 651-660 of 10588 results for "".
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
https://reachmd.com/clinical-practice/ophthalmology/real-world-switching-to-faricimab-from-legacy-anti-vegfs-in-wet-amd/54288/What were the functional, anatomic, and safety results of switching wet AMD patients to faricimab (Vabysmo, Genentech) from a legacy anti-VEGF agent? Maria Berrocal, MD, is joined by Lejla Vajzovic, MD, as they review the results of a real-world study assessing 84 eyes with wet AMD that underwent atIdentifying Gaps in Kidney Care for People Living with HIV: Insights from a Survey
https://reachmd.com/programs/clinicians-roundtable/identifying-gaps-in-kidney-care-for-people-living-with-hiv-insights-from-a-survey/32828/Clinicians treating people living with HIV face growing challenges in assessing and managing kidney dysfunction. In a national survey presented at IDWeek 2025, Drs. Amanda Binkley and William Short uncovered significant variability in renal assessment methods, drug dosing practices, and nephrology rPhysicians and Surrogate Decision Makers for Critically Ill Patients Often Disagree on Patient's Prognosis
https://reachmd.com/programs/the-jama-report/physicians-and-surrogate-decision-makers-critically-ill-patients-often-disagree-patients-prognosis/8157/A new study found that surrogates were substantially more optimistic about a patient's prognosis compared to physicians.Euthanasia and Physician-Assisted Suicide Increasingly Being Legalized
https://reachmd.com/programs/the-jama-report/euthanasia-and-physician-assisted-suicide-increasingly-being-legalized/8230/Euthanasia and physician-assisted suicide (PAS) in the U.S., Canada, and Europe are increasingly being legalized, but remain relatively uncommon.How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
https://reachmd.com/programs/neurofrontiers/how-alzheimers-and-lewy-body-pathology-impact-caa-risk-factors/17830/Dive into a study that explored how the presence of Lewy body pathology alongside Alzheimer’s changes the risk factors for cerebral amyloid angiopathy.Surgical Management of Crohn's Disease & Ulcerative Colitis
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/surgical-management-crohns-disease-and-ulcerative-colitis/9641/Dr. Michael Kwiatt explains what patients need to know about surgery and IBDJournal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
https://reachmd.com/programs/Audioabstracts/journal-cystic-fibrosis-efficacy-safety-levofloxacin-inhalation-solution-apt-1026/8217/A study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.Exploring the Future of Psoriasis Treatment with Oral Agents
https://reachmd.com/programs/dermconsult/future-psoriasis-treatment-oral-agents/39685/Novel oral therapies are expanding the possibilities for personalized care in psoriasis, offering biologic-like efficacy with greater flexibility. Join Dr. Christopher Bunick as he discusses the evolving role of oral agents in the future of psoriasis treatment and the importance of real-world data iScientific Advancements Leading to New Options to Manage Aesthetic Concerns
https://reachmd.com/topics/injectables/scientific-advancements-leading-to-new-options-to-manage-aesthetic-concerns/35185/Updates on some of the latest developments in minimially invasive aestheticsReduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
https://reachmd.com/programs/acc-action-center/reduction-of-bleeding-with-tranexamic-acid-after-noncardiac-surgery/13774/Explore the safety and efficacy of tranexamic acid in patients undergoing noncardiac surgery in this recap of a session from ACC 2022.